与帕利哌酮长效注射剂相关的非典型抗精神病药恶性综合征：一例报告。 - Suppr | 超能文献

Atypical Neuroleptic Malignant Syndrome Associated With Paliperidone Long-Acting Injection: A Case Report.

作者信息

Langley-DeGroot Michael, Joshi Yash, Lehman David, Rao Sanjai

机构信息

Department of Psychiatry, University of California, San Diego Health System, La Jolla, CA

出版信息

J Clin Psychopharmacol. 2016 Jun;36(3):277-9. doi: 10.1097/JCP.0000000000000507.

DOI:10.1097/JCP.0000000000000507

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Atypical Neuroleptic Malignant Syndrome Associated With Paliperidone Long-Acting Injection: A Case Report.与帕利哌酮长效注射剂相关的非典型抗精神病药恶性综合征：一例报告。

J Clin Psychopharmacol. 2016 Jun;36(3):277-9. doi: 10.1097/JCP.0000000000000507.

2

Late-onset Neuroleptic Malignant Syndrome Associated With Paliperidone Long-acting Injection and Lithium: A Case Report.

J Clin Psychopharmacol. 2021;41(3):333-335. doi: 10.1097/JCP.0000000000001370.

3

Pharmacokinetics, safety, and tolerability of paliperidone palmitate 3-month formulation in patients with schizophrenia: A phase-1, single-dose, randomized, open-label study.帕利哌酮棕榈酸酯3个月剂型在精神分裂症患者中的药代动力学、安全性及耐受性：一项1期单剂量随机开放标签研究。

J Clin Pharmacol. 2016 Mar;56(3):330-9. doi: 10.1002/jcph.597. Epub 2015 Oct 5.

4

Mortality rate is associated with paliperidone palmitate, risperidone long-acting injection, and oral paliperidone administration.死亡率与棕榈酸帕利哌酮、长效注射用利培酮及口服帕利哌酮有关。

Asian J Psychiatr. 2018 Jun;35:28. doi: 10.1016/j.ajp.2018.04.033. Epub 2018 Apr 24.

5

Hypothermia Associated With Paliperidone Depot Injection in Schizophrenia Patient: A Case Report.

J Clin Psychopharmacol. 2020 Jan/Feb;40(1):86-87. doi: 10.1097/JCP.0000000000001155.

6

A qualitative study of patient experience when switching from paliperidone palmitate once monthly (PP1M) to paliperidone palmitate three monthly (PP3M) long-acting injectable antipsychotic.一项关于患者从每月一次棕榈酸帕利哌酮（PP1M）换用每三个月一次棕榈酸帕利哌酮（PP3M）长效注射用抗精神病药物时的体验的定性研究。

Schizophr Res. 2019 Feb;204:443-444. doi: 10.1016/j.schres.2018.09.012. Epub 2018 Sep 18.

7

Low Incidence of Neuroleptic Malignant Syndrome Associated With Paliperidone Palmitate Long-Acting Injectable: A Database Report and Case Study.与棕榈酸帕利哌酮长效注射剂相关的抗精神病药恶性综合征发生率低：一项数据库报告及病例研究

J Clin Psychopharmacol. 2019 Mar/Apr;39(2):180-182. doi: 10.1097/JCP.0000000000001019.

8

Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics.对当前口服非典型抗精神病药物不满意的患者立即或延迟换用棕榈酸帕利哌酮的满意度

Int Clin Psychopharmacol. 2015 Nov;30(6):320-8. doi: 10.1097/YIC.0000000000000093.

9

Pharmacokinetic profile after multiple deltoid or gluteal intramuscular injections of paliperidone palmitate in patients with schizophrenia.精神分裂症患者接受帕利哌酮棕榈酸酯多次三角肌或臀肌肌内注射后的药代动力学特征。

Clin Pharmacol Drug Dev. 2015 Jul;4(4):270-8. doi: 10.1002/cpdd.144. Epub 2014 Aug 28.

10

Benefit-risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia.帕利哌酮口服缓释片与每月注射剂用于精神分裂症维持治疗的获益-风险评估

Int Clin Psychopharmacol. 2016 Nov;31(6):315-22. doi: 10.1097/YIC.0000000000000141.

引用本文的文献

1

Paliperidone-induced neuroleptic malignant syndrome: A case report.帕利哌酮诱发的抗精神病药恶性综合征：一例报告。

Medicine (Baltimore). 2025 Mar 7;104(10):e41171. doi: 10.1097/MD.0000000000041171.

2

[Neuroleptic malignant syndrome].[抗精神病药恶性综合征]

Nervenarzt. 2018 Mar;89(3):300-310. doi: 10.1007/s00115-017-0463-3.